Biotech | August 12, 2025
Sartorius and Nanotein Technologies partner to advance cell therapy manufacturing
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Baruah will lead strategy, growth, and transformation across the HLS vertical, focusing on expanding digital health capabilities and accelerating AI adoption
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
Thyrocare Technologies has reported total income of Rs. 179.97 crores during the period ended September 30, 2024
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
